Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review S Chatterji, E Krzoska, CW Thoroughgood, J Saganty, P Liu, B Elsberger, ... The Lancet Oncology 24 (2), e74-e85, 2023 | 12 | 2023 |
Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer DP McClurg, G Urquhart, T McGoldrick, S Chatterji, Z Miedzybrodzka, ... Cancers 14 (13), 3175, 2022 | 6 | 2022 |
Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer S Chatterji, JM Niehues, M van Treeck, CML Loeffler, OL Saldanha, ... NPJ Breast Cancer 9 (1), 91, 2023 | 1 | 2023 |
Exploring the One Health Paradigm in Male Breast Cancer K Luo-Yng Tay, G Cowan, S Chatterji, G Conti, V Speirs Journal of Mammary Gland Biology and Neoplasia 29 (1), 1-10, 2024 | | 2024 |
Deep Learning-based ERa Prediction Model Underperforms in Male Breast Cancer: Further Evidence of Breast Cancer Sex-based Disparities S Chatterji, J Niehues, M van Treeck, O Saldanha, G Veldhuizen, D Cifci, ... JOURNAL OF PATHOLOGY 261 (SUPPL 1), S38-S38, 2023 | | 2023 |
Deep learning models predicting hormone receptor status in breast cancer trained on females do not generalize to males: further evidence of sex-based disparity in breast cancer S Chatterji, J Niehues, M van Treeck, C Loeffler, O Saldanha, ... | | 2023 |
Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer. Cancers 2022, 14, 3175 DP McClurg, G Urquhart, T McGoldrick, S Chatterji, Z Miedzybrodzka, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
Correlation of GSTP1 Polymorphism with Severity of Prostate Cancer in an Eastern Indian Population S Roy, A Dasgupta, S Chatterji, D Karmakar BP International, 2019 | | 2019 |